Gleevec and BMT

Last Modified: March 6, 2005

Share article


Question

Dear OncoLink "Ask The Experts,"
Our 14 year old son was diagnosed with Chronic Myelogenous Leukemia 6 weeks ago. He is on Gleevec. We have been considering Bone Marrow Transplant but heard that Gleevec may be contraindicated in doing a BMT. Can you shed any light on this?

Answer

Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:

Being on Gleevec in no way makes patients ineligible for a bone marrow transplant. However, sometimes, the Gleevec is discontinued for some period of time before the transplant is performed.


News
Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.



I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More